发明名称 (-)-5-(3-Chlorophenyl)-[alpha]-(4-chlorophenyl)-[alpha]-(1- methyl-1H-imidazol-5-yl)tetrazolo-[1,5-a]quinazoline-7- methanamine, method of preparation and use thereof, pharmaceutical preparation containing it and a method of preparation thereof
摘要 <p>It is described (-)-5-(3-Chlorophenyl)-[alpha]-(4- chlorophenyl)-[alpha]-(1-methyl-1<i>H</i >-imidazol-5- yl)tetrazolo-[1,5-a]quinazoline-7-methanamine and its pharmaceutically acceptable acid addition salts, method of their preparation by separation from particular racemic mixtures and the use of such compounds in medicine especially for the treatment of cancer. It is also described a pharmaceutical preparation containing some of these substances and method of preparation thereof.</p>
申请公布号 SK285699(B6) 申请公布日期 2007.06.07
申请号 SK20030000050 申请日期 2001.06.13
申请人 JANSSEN PHARMACEUTICA N. V. 发明人 VENET MARC GASTON;ANGIBAUD PATRICK RENE;END DAVID WILLIAM
分类号 A61K31/519;A61P35/00;C07D487/04 主分类号 A61K31/519
代理机构 代理人
主权项
地址